Historical Stock Price
| Home |
| Free Dividend Report |
| Stock Splits Calendar |
| ABEO Historical Stock Prices |
| Preferred Stock Newsletter |
| ABEO Options Chain |
| Stock Message Boards |
Abeona Therapeutics (ABEO) has the following price history information. Looking back at ABEO historical stock prices for the last five trading days, on January 30, 2023, ABEO opened at $2.65, traded as high as $2.67 and as low as $2.52, and closed at $2.52. Trading volume was a total of 104.30K shares. On January 31, 2023, ABEO opened at $2.51, traded as high as $2.57 and as low as $2.50, and closed at $2.52. Trading volume was a total of 195.30K shares. On February 01, 2023, ABEO opened at $2.55, traded as high as $2.65 and as low as $2.52, and closed at $2.65. Trading volume was a total of 105.20K shares. On February 02, 2023, ABEO opened at $2.68, traded as high as $2.84 and as low as $2.62, and closed at $2.82. Trading volume was a total of 254.60K shares. On February 03, 2023, ABEO opened at $2.77, traded as high as $2.90 and as low as $2.72, and closed at $2.76. Trading volume was a total of 158.40K shares.
ABEO Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Abeona Therapeutics shares, starting with a $10,000 purchase of ABEO, and working forward through the historical stock price information to today.
|
Growth of $10,000.00 Without Dividends Reinvested |
||
| Start date: | 02/06/2013 | |
| End date: | 02/03/2023 | |
| Start price/share: | $12.25 | |
| End price/share: | $2.76 | |
| Dividends collected/share: | $0.00 | |
| Total return: | -77.47% | |
| Average Annual Total Return: | -13.85% | |
| Starting investment: | $10,000.00 | |
| Ending investment: | $2,252.84 | |
| Years: | 10.00 | |
 | |||||
| ABEO Historical Price Range | |||||
| Date | Open | High | Low | Close | Volume |
| 01/30/2023 | $2.65 | $2.67 | $2.52 | $2.52 | 104.30K |
| 01/31/2023 | $2.51 | $2.57 | $2.50 | $2.52 | 195.30K |
| 02/01/2023 | $2.55 | $2.65 | $2.52 | $2.65 | 105.20K |
| 02/02/2023 | $2.68 | $2.84 | $2.62 | $2.82 | 254.60K |
| 02/03/2023 | $2.77 | $2.90 | $2.72 | $2.76 | 158.40K |
|
| About Abeona Therapeutics |
| Abeona Therapeutics is a clinical-stage biopharmaceutical company developing cell and gene therapies for life-threatening rare genetic diseases. Co.'s primary clinical program is EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa, which is in the pivotal Phase 3 VIITAL™ clinical trial. Co. is developing additional adeno-associated virus (AAV)-based gene therapies designed to treat ophthalmic and other diseases and AAV-based gene therapies using the AIM™ capsid platform that Co. has licensed from University of North Carolina at Chapel Hill, and internal AAV vector research programs. |
| ABEO Historical Closing Prices | |
| Date | Close |
| 01/30/2023 | $2.52 |
| 01/31/2023 | $2.52 |
| 02/01/2023 | $2.65 |
| 02/02/2023 | $2.82 |
| 02/03/2023 | $2.76 |
| Healthcare Historical Prices |
| ABEO is categorized under the Healthcare sector; below are some other companies in the same sector:
ABIO Historical Stock Prices Also explore: ABEO shares outstanding history
|
Free ABEO Email Alerts:
